Singapore vs Slovenia: Access to anti-retroviral drugs, female
Singapore
84.0%
in 2023
Slovenia
83.0%
in 2024
Singapore rank
50th
Slovenia rank
53rd
Access to anti-retroviral drugs, female over time
- Singapore
- Slovenia
How they compare
Singapore currently reports 84.0% against 83.0% in Slovenia, a difference of 1.0%.
The two have swapped places 5 times across 24 shared years of data; in 2000 it was Slovenia ahead.
Singapore ranks 50th and Slovenia ranks 53rd of 141 countries.
Across the 3 decades both report, Singapore averaged higher in 2 and Slovenia in 1.
Head to head by decade
| Decade | Singapore | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.9% | 28.3% | 8.4% | Slovenia |
| 2010s | 59.6% | 57.1% | 2.5% | Singapore |
| 2020s | 80.8% | 71.5% | 9.2% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Singapore or Slovenia?
- Singapore, at 84.0% against 83.0% in Slovenia as of 2023.
- What is the difference in access to anti-retroviral drugs, female between Singapore and Slovenia?
- 1.0%, with Singapore ahead.
- How many years of comparable data are there for Singapore and Slovenia?
- 24 years are reported by both, from 2000 to 2023.
- How do Singapore and Slovenia rank globally for access to anti-retroviral drugs, female?
- Singapore ranks 50th and Slovenia ranks 53rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.